Viewing Study NCT03490292


Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2025-12-30 @ 3:39 AM
Study NCT ID: NCT03490292
Status: COMPLETED
Last Update Posted: 2024-07-26
First Post: 2018-02-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
Sponsor: University of Wisconsin, Madison
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Esophageal Cancer View
None GastroEsophageal Cancer View
Keywords: